The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: Effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques

Brain Research

Volumn 993, Issue 1-2, 2003, Pages 42-53

  Haga, Kristin K ^a,b   Gregory, Lloyd J ^b,c   Hicks, Caroline A ^d   Ward, Mark A ^d   Beech, John S ^b,e   Bath, Phillip W ^f   Williams, Steven C R ^b   O'Neill, Michael J ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ELI LILLY AND COMPANY   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cerebral ischaemia; Histology; Magnetic resonance spectroscopy; Mongolian gerbil; Neuroprotection; Nitric oxide (NO); Rat; TRIM

Indexed keywords

1,2 TRIFLUOROMETHYLPHENYLIMIDAZOLE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BIOASSAY; BRAIN ISCHEMIA; CONTROLLED STUDY; DENSITY; DISEASE COURSE; DRUG EFFECT; GERBIL; HIPPOCAMPUS; HISTOLOGY; MALE; NERVE CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSION; PRIORITY JOURNAL; RAT; REDUCTION;

EID: 0345714760     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.08.063     Document Type: Article

References (52)

1. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
2. Beckman J.J., Beckman T.W., Chen J., Marshall D.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87:1990;6120-6124.
3. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308.
4. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
5. Belayev L., Alonso O.F., Busto R., Zhao W., Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke. 27:1996;1616-1622.
6. Block F., Schmitt W., Schwarz M. The antioxidant LY231617 ameliorates functional and morphological sequelae induced by global ischaemia in rats. Brain Res. 694:1995;308-311.
7. Buisson A., Margaill I., Callebert J., Plotkine M., Boulu R.G. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J. Neurochem. 61:1993;690-696.
8. G-nitro-L-arginine methyl ester protects against lipid peroxidation in the gerbil following cerebral ischaemia. Eur. J. Pharmacol. 285:1995;203-206.
9. Cash D., Beech J.S., Rayne R.C., Bath P.M.W., Meldrum B.S., Williams S.C.R. Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain. Brain Res. 905:2001;91-103.
10. Chabrier P.-E., Demerlé-Pallardy C., August M. Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. CMLS Cell. Mol. Life Sci. 55:1999;1029-1035.
11. Choi D.W. Nitric oxide: foe or friend to the injured brain? Proc. Natl. Acad. Sci. U. S. A. 90:1993;9741-9743.
12. Clemens J.A., Saunders R.D., Ho P.P., Phebus L.A., Panetta J.A. The antioxidant LY231617 reduces global ischemic neuronal injury in rats. Stroke. 24:1993;716-723.
13. Coert B.A., Anderson R.E., Meyer F.B. A comparative study of the effects of two nitric oxide synthase inhibitors and two nitric oxide donors on temporary focal cerebral ischemia in the Wistar rat. J. Neurosurg. 90:1999;232-338.
14. Dawson D.A. Nitric oxide, focal cerebral ischemia: multiplicity of actions and diverse outcomes. Cerebrovasc. Brain Metab. Rev. 6:1995;299-324.
15. Dawson D.A., Graham D.I., McCulloch J., Macrae I.M. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Br. J. Pharmacol. 113:1994;247-253.
16. Dawson V.L., Kizushi V.M., Huang P.L., Snyder S.H., Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16:1996;2479-2487.
17. Escott K.J., Beech J.S., Haga K.K., Williams S.C., Meldrum B.S., Bath P.M. Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitroindazole after focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18:1998;281-287.
18. Garthwaite J., Garthwaite G., Palmer R.M.J., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172:1989;413-416.
19. Green I.C., Chabrier P.-E. Nitric oxide: from basic research to clinical application. Drug Discov. Today. 4:1999;47-49.
20. Gregory L.J., O'Neill M.J., Nunn J.A., Gray J.A., Williams S.C.R. Diffusion weighted MRI detects early neuropathology following four vessel occlusion ischaemia in the rat. J. Magn. Reson. Imaging. 14:2001;207-214.
21. Hall E.D., Braughler J.M. Central nervous system trauma and stroke: II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 6:1989;303-313.
22. Handy R.L.C., Wallace P., Gaffen Z.A., Whitehead K.J., Moore P.K. The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br. J. Pharmacol. 116:1995;2349-2350.
23. Handy R.L.C., Harb H.L., Wallace P., Gaffen Z.A., Whitehead K.J., Moore P.K. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 119:1996;423-431.
24. Harukuni I., Traystman R.J., Kirsch J.R. Effect of AR-R 17477, a potent neuronal nitric oxide synthase inhibitor, on infarction volume resulting from permanent focal ischaemia in rats. Crit. Care Med. 27:1999;2508-2511.
25. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
26. Huang Z.H., Huang P.L., May J.Y., Meng W., Ayata C., Fishman M.C., Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16:1996;981-987.
27. G-nitro-L-arginine methyl ester. Stroke. 30:1999;669-677.
28. Liszczak T.M., Hedley-Whyte E.T., Adams J.F., Han D.H., Kolluri V.S., Vacanti F.X., Heros R.C., Zervas N.T. Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol. 56:1984;150-157.
29. Mésenge C., Verrecchia C., Allix M., Boulu R.G., Plotkine M. Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J. Neurotrauma. 13:1996;209-214.
30. Moncada S., Plamer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
31. Moore P.K., Handy R.L.C. Selective inhibitors of neuronal nitric oxide synthase - is no NOS really good NOS for the nervous system? Trends Pharmacol. Sci. 18:1997;204-211.
32. Nagafuji T., Sugiyama M., Makino T., Muto A., Naito S. Nitric oxide synthase in?: possible contribution of nitric oxide synthase activation in brain microvessels to cerebral ischemic injury. Mol. Chem. Neuropathol. 26:1995;107-155.
33. Nowicki J.P., Duval D., Poignet H., Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204:1991;339-340.
34. Olsen S.P., Moller A., Mordvintcev P.I., Busse R., Mulch A. Regional measurements of NO formed in vivo during brain ischemia. Acta Neurol. Scand. 95:1997;219-224.
35. O'Neill M.J., Hicks C., Ward M. Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia. Eur. J. Pharmacol. 310:1996;115-122.
36. O'Neill M.J., Hicks C.A., Ward M.A., Panetta J.A. Neuroprotective effects of the antioxidant LY231617 and neuronal NO synthase inhibitors in global cerebral ischaemia. Brain Res. 760:1997;170-178.
37. O'Neill M.J., Bogaert L., Hicks C.A., Bond A., Ward M.A., Ebinger G., Ornstein P.L., Michotte Y., Lodge D. LY377770, a novel iGlu5 kainate antagonist with neuroprotective properties in global and focal cerebral ischaemia. Neuropharmacology. 39:2000;1575-1588.
38. O'Neill M.J., Murray T.K., McCarty D.R., Hicks C.A., Dell C.P., Patrick K.E., Ward M.A., Osborne D.J., Wiernicki T.R., Roman C.R., Lodge D., Fleisch J.H., Singh J.P. ARL 17477, a selective neuronal nitric oxide synthase inhibitor, with neuroprotective effects in models of global and focal cerebral ischaemia. Brain Res. 871:2000;234-244.
39. Panahian N., Yoshida T., Huang P.L., Hedley-Whyte E.T., Dalkara T., Fishman M.C., Moskowitz M.A. Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase. Neuroscience. 72:1996;343-354.
40. Pulsinelli W.A., Brierley J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 10:1979;267-272.
41. Schulz J.B., Huang P.L., Matthews R.T., Passov D., Fishman M.C., Beal M.F. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67:1996;430-433.
42. Siesjö B.K. Pathophysiology and treatment of focal cerebral ischemia: Part I. Pathophysiology. J. Neurosurg. 77:1992;169-184.
43. Togashi H., Mori K., Ueno K.I., Matsumoto M., Suda N., Saito H., Yoshioka M. Consecutive evaluation of nitric oxide production after transient cerebral ischemia in the rat hippocampus using in vivo brain microdialysis. Neurosci. Lett. 240:1998;53-57.
44. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71:1991;1185-1195.
45. Wada K., Chatzipanteli K., Buto R., Dietrich W.D. Role of nitric oxide in traumatic brain injury in the rat. J. Neurosurg. 89:1998;807-818.
46. Wada K., Chatzipanteli K., Buto R., Dietrich W.D. Effects of L-NAME and 7-NI on NOS catalytic activity and behavioral outcome after traumatic brain injury in the rat. J. Neurotrauma. 16:1999;203-212.
47. Wei G., Dawson V.L., Zweier J.L. Role of neuronal and endothelial nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia. Biochim. Biophys. Acta. 1455:1999;23-34.
48. Yoshida T., Limmroth V., Irikura K., Moskowitz M.A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14:1994;924-929.
49. Yoshida T., Waeber C., Huang Z., Moskowitz M.A. Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion. Neurosci. Lett. 194:1995;214-218.
50. Zea Longa E., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
51. Zhang F., Casey R.M., Ross M.E., Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 27:1996;317-323.
52. Zhang Z.G., Reif D., MacDonald J., Tang W.X., Kamp D.K., Gentile R.J., Shakespeare W.C., Murray R.J., Chopp M. ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16:1996;599-604.